Buy TB-500 10 mg + bacteriostatic water

€34.47

TB-500, 10 mg, with bacteriostatic water, should be specified as either Ac-LKKTETQ or full-length thymosin Ξ²4 after CoA verification. Pharma Research .eu provides documented European laboratory supply subject to sequence-specific identity testing.

Category:
Description

Buy TB-500, 10 mg + Bacteriostatic Water, for Advanced Laboratory Research in Europe

β€œTB-500” is an inconsistent commercial designation. In current research catalogues, it may refer to the N-acetylated seven-residue thymosin-Ξ²4 fragment Ac-LKKTETQ, or to a 43-residue thymosin-Ξ²4 sequence. These are different chemical entities with different formulae, molecular masses and analytical requirements. This product page assumes the seven-residue TB-500 fragment, but Pharma Research .eu must verify the sequence on the batch CoA before procurement.artemispeptides+2

Uncompromising Purity and Analytical Characterisation

The seven-residue TB-500 fragment should be specified as:

Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln-OH

This sequence corresponds to residues 17–23 of thymosin Ξ²4 and includes an N-terminal acetyl group. It should not be confused with full-length 43-residue thymosin Ξ²4, which is reported at approximately 4,963 Da and has a substantially different molecular formula.apexlaboratory+1

For laboratory procurement, the suitable target is β‰₯99.0% purity by RP-HPLC, subject to confirmation by the actual batch-specific certificate of analysis. Research references commonly identify the seven-residue fragment as an HPLC- and mass-spectrometry-characterised laboratory material, but supplier claims must be checked against the actual lot documentation.apexlaboratory+1

A complete CoA should include:

  • RP-HPLC purity percentage, analytical method and chromatogram.

  • LC-MS, ESI-MS or high-resolution MS identity confirmation.

  • Full sequence and N-terminal acetylation status.

  • Confirmation of the free C-terminal acid.

  • Molecular formula and molecular-mass assignment.

  • Free-peptide, acetate or other salt-form information.

  • Visual appearance of the lyophilised material.

  • Residual-solvent results from synthesis and purification.

  • Water or residual-moisture content, where measured.

  • Heavy-metal or elemental-impurity results where included in the quality programme.

  • Lot number, manufacture date, retest date and storage requirements.

For the commonly reported acetylated fragment, the formula is Cβ‚ƒβ‚ˆHβ‚†β‚ˆN₁₀O₁₄, with average molecular mass approximately 889.0–889.02 Da. CAS Registry Number 885340-08-9 and PubChem CID 62707662 are widely associated with this seven-residue material.pubchem.ncbi.nlm.nih+2

The fragment is generally supplied as a white to off-white lyophilised powder. Visual inspection can identify gross discolouration, vial damage or visible contamination, but cannot establish identity or purity. Analytical release should combine appearance assessment with RP-HPLC and mass-spectral confirmation.

High purity is important because unacetylated LKKTETQ, incomplete synthesis products, deletion sequences, oxidation products, residual reagents and thymosin Ξ²4 contamination can alter retention time, ionisation, solubility and assay response. A product labelled β€œTB-500” without an explicit sequence is not sufficiently defined for reliable laboratory procurement.

The accompanying bacteriostatic water is a separate reagent and should have its own label, expiry date, preservative information and documentation. Preservatives and ions may affect chromatography, peptide recovery, pH or cellular assay performance.

Principal Laboratory Applications and Research Methodologies

The seven-residue TB-500 fragment is suitable for controlled laboratory research involving peptide analytics, synthetic-peptide characterisation and in vitro biochemical model development. All applications should be conducted by qualified personnel within an appropriately governed university, CRO, pharmaceutical R&D or analytical laboratory.

RP-HPLC and LC-MS method development. Ac-LKKTETQ can be used as a defined short-peptide analyte for retention-time assignment, intact-mass confirmation, impurity profiling and sample-recovery studies. The analytical method should distinguish the acetylated fragment from the free N-terminal peptide and from full-length thymosin Ξ²4.

Sequence and modification verification. Laboratories may compare acetylated and non-acetylated forms to assess changes in retention, charge state, ionisation and recovery. The presence of the N-terminal acetyl group should be confirmed by mass spectrometry rather than inferred from the product name.

Stability and degradation research. Researchers may examine the influence of temperature, light, pH, oxidation, container material and freeze–thaw exposure. Stability-indicating methods should distinguish hydrolysis, oxidation, adsorption and incomplete dissolution.

In vitro biochemical assays. A verified lot may be incorporated into controlled cell-free or cellular models examining peptide-associated biochemical responses. Studies should include vehicle controls, blank matrices, concentration confirmation and independent testing of the bacteriostatic-water formulation.

The 10 mg quantity corresponds to approximately 11.2 Β΅mol using the reported molecular mass of 889.0 g/mol. If the product is instead full-length 43-residue thymosin Ξ²4, 10 mg corresponds to only approximately 2.0 Β΅mol. This substantial difference is why the sequence must be resolved before publishing concentration or procurement information.

The bacteriostatic-water component should be assessed separately for compatibility with LC-MS and in vitro workflows. Preservatives may require solvent blanks, matrix-effect testing and cell-compatibility studies.

Compound Stability, Optimal Storage, and Safe Handling Protocols

The lyophilised seven-residue TB-500 fragment should remain sealed, dry and protected from light until required for a validated laboratory procedure. Research references commonly recommend low-temperature storage near βˆ’20Β°C, although the lot-specific CoA should take precedence.artemispeptides+1

Recommended controls include:

  • Store unopened lyophilised TB-500 at approximately βˆ’20Β°C unless the CoA specifies otherwise.

  • Consider βˆ’80Β°C for extended archival storage where supported by the stability programme.

  • Keep the vial tightly closed, dry and protected from direct light.

  • Allow a sealed vial to reach room temperature before opening to minimise condensation.

  • Use low-binding tubes where adsorption could affect recovery.

  • Prepare aliquots if repeated access is expected.

  • Store short-term aqueous solutions at 2–8Β°C only where validated.

  • Use frozen aliquots for longer-term solution storage when supported by stability data.

  • Avoid repeated freeze–thaw cycles.

  • Record sequence, solvent, concentration, preparation date, operator and storage history.

Prepared solutions may experience adsorption, concentration loss, pH-dependent changes or physical instability. A clear solution should not automatically be assumed to retain its nominal concentration or molecular integrity without HPLC or LC-MS confirmation.

Reconstitution should be performed using a validated laboratory procedure. Add bacteriostatic water gradually, allow the powder to hydrate and mix gently. Avoid vigorous agitation unless demonstrated to be compatible with the method. If precipitation, turbidity or unexpected colour change occurs, investigate the solution analytically before use.

Handling should follow the current SDS and institutional chemical-risk assessment. Appropriate precautions generally include a certified fume hood or suitable local containment, nitrile gloves, safety goggles and a laboratory coat. Avoid aerosol generation and direct contact with the powder or solution. Dispose of contaminated materials through approved institutional chemical and laboratory-waste procedures.

Technical Specifications and Molecular Attributes

Attribute Specification
Product TB-500, 10 mg, supplied with bacteriostatic water
Identity warning β€œTB-500” may denote either a 7-residue fragment or a 43-residue thymosin Ξ²4 material
Assumed product form N-acetylated seven-residue fragment
Sequence Ac-Lys-Lys-Thr-Glu-Thr-Gln? No β€” verify carefully: canonical fragment is Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln-OH
Correct sequence Ac-LKKTETQ-OH
Residue count 7 amino acids
IUPAC name Full systematic name should be confirmed on the CoA; sequence notation is preferred for procurement
CAS Registry Number 885340-08-9 for the commonly reported acetylated fragment
Molecular formula Cβ‚ƒβ‚ˆHβ‚†β‚ˆN₁₀O₁₄
Average molecular mass Approximately 889.0–889.02 g/mol
Physical state and colour Lyophilised white to off-white powder
Solubility profile Aqueous reconstitution may be feasible; solvent and buffer compatibility require assay-specific validation
Typical purity Proposed target β‰₯99.0% by RP-HPLC; verify the actual lot-specific result
Identity testing LC-MS, ESI-MS or high-resolution MS
Companion reagent Bacteriostatic water; volume and formulation should be confirmed on the packaging
Long-term storage Typically βˆ’20Β°C, sealed and protected from light and moisture

Important sequence correction: the canonical seven-residue fragment is Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln-OH (Ac-LKKTETQ-OH). This should be checked against the label and CoA before publication. Full-length 43-residue thymosin Ξ²4 must be listed separately with its own formula and molecular mass.artemispeptides+2

Pharma Research .eu: Your Premier EU Vendor for High-Purity Reagents

Pharma Research .eu can position this TB-500 format as a documented European laboratory reagent, provided the sequence ambiguity is resolved before listing or shipment. The product file should identify whether the material is Ac-LKKTETQ or full-length 43-residue thymosin Ξ²4 and should include the corresponding CoA, SDS, purity result, LC-MS identity data, salt form and storage instructions.

Any claim that Pharma Research .eu operates an ISO 9001-certified quality-management system should be supported by a current certificate identifying the issuing body, scope and validity. Claims concerning discreet or temperature-controlled logistics across EU member states should likewise be verified for the destination, carrier route, packaging and applicable transport requirements.

A quality-focused supplier should be able to discuss:

  • The exact TB-500 sequence supplied.

  • Seven-residue fragment versus 43-residue thymosin Ξ²4.

  • N-terminal acetylation and C-terminal group.

  • RP-HPLC purity and LC-MS identity testing.

  • Residual solvents, moisture and elemental-impurity reporting.

  • Packaging configuration and container-closure integrity.

  • Compatibility of bacteriostatic water with analytical workflows.

  • Storage, transport and documentation requirements.

Until the sequence is verified, the product should be described as a TB-500-designated research peptide with identity pending CoA confirmation. The material is intended strictly for controlled laboratory research and analytical use by qualified personnel under applicable institutional procedures.

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Buy TB-500 10 mg + bacteriostatic water”

Your email address will not be published. Required fields are marked *

Shipping & Delivery

MAECENAS IACULIS

Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.

ADIPISCING CONVALLIS BULUM

  • Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
  • Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
  • Diam parturient dictumst parturient scelerisque nibh lectus.

Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisqueΒ vestibulum amet elit ut volutpat.